Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.

PloS One
David A EnglerGayatry Mohapatra

Abstract

Ovarian cancer is the fifth leading cause of cancer death in women. Ovarian cancers display a high degree of complex genetic alterations involving many oncogenes and tumor suppressor genes. Analysis of the association between genetic alterations and clinical endpoints such as survival will lead to improved patient management via genetic stratification of patients into clinically relevant subgroups. In this study, we aim to define subgroups of high-grade serous ovarian carcinomas that differ with respect to prognosis and overall survival. Genome-wide DNA copy number alterations (CNAs) were measured in 72 clinically annotated, high-grade serous tumors using high-resolution oligonucleotide arrays. Two clinically annotated, independent cohorts were used for validation. Unsupervised hierarchical clustering of copy number data derived from the 72 patient cohort resulted in two clusters with significant difference in progression free survival (PFS) and a marginal difference in overall survival (OS). GISTIC analysis of the two clusters identified altered regions unique to each cluster. Supervised clustering of two independent large cohorts of high-grade serous tumors using the classification scheme derived from the two initial clusters...Continue Reading

References

Jul 1, 1991·Gynecologic Oncology·H R Balvert-LochtM T Verhagen-Teulings
Sep 1, 1990·Gynecologic Oncology·V V BakerD Miller
May 1, 1988·Mutation Research·J L Bos
Sep 1, 1986·The Laryngoscope·W L Meyerhoff, J Truelson
May 1, 1995·Molecular and Cellular Biology·M OhtsuboM Pagano
Sep 15, 1993·Journal of the National Cancer Institute·M F KohlerA Berchuck
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·O SchuldinerN Benvenisty
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J T MaderJ H Calhoun
Jan 6, 1999·Proceedings of the National Academy of Sciences of the United States of America·Y YuR C Bast
Jan 20, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R P Perez
Jan 23, 1999·Nature Genetics·L ShayestehJ W Gray
Apr 29, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A du BoisJ T Thigpen
Apr 28, 2000·The International Journal of Biochemistry & Cell Biology·A Cuenda
Aug 30, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P NeijtH C van Houwelingen
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A. KoulÅ. Borg Å
Feb 13, 2002·Seminars in Oncology·David G Mutch
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sridhar Ramaswamy, Todd R Golub
Oct 10, 2002·British Journal of Cancer·J SandercockW Qian
Feb 15, 2003·Gynecologic Oncology·Joe W GrayGordon B Mills
Mar 18, 2003·International Journal of Cancer. Journal International Du Cancer·Sebastian F SchoppmannPeter Birner
Mar 20, 2003·Journal of the National Cancer Institute·Gad SingerIe-Ming Shih
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Dec 6, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J J Biagi, E A Eisenhauer
Dec 12, 2003·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·Jeffrey D SeidmanBrigitte M Ronnett
Jan 30, 2004·Cancer Cell·Robert F OzolsThomas C Hamilton
Jul 3, 2004·Genome Research·Frédéric CollandJean-Michel Gauthier
Aug 12, 2004·International Journal of Cancer. Journal International Du Cancer·Nozomu YanaiharaJun Yokota
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Oct 27, 2004·Nature Medicine·Kwai Wa ChengGordon B Mills
Oct 27, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dimitrios SpentzosStephen A Cannistra
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Jan 22, 2005·Gynecologic Oncology·Jennifer WilliamsJ Rebecca Liu

❮ Previous
Next ❯

Citations

Jan 25, 2013·International Journal of Molecular Sciences·Dominic VargaLisa Wiesmüller
Sep 11, 2013·The Journal of Clinical Investigation·Wei WeiMichael J Birrer
Dec 7, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·W WeiM J Birrer
May 14, 2016·Expert Review of Molecular Diagnostics·Diana P EnglishAlessandro D Santin
Nov 24, 2016·BMC Cancer·Fatemeh KavehHiroko K Solvang
Jan 1, 2013·Molecular Oncology·Chang K SungThomas Benjamin
Aug 9, 2019·Interdisciplinary Sciences, Computational Life Sciences·Ashwinder Singh Yogita
Apr 6, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Brett M ReidThomas A Sellers

❮ Previous
Next ❯

Software Mentioned

GISTIC

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Barrett Esophagus

Barrett’s esophagus if a serious complication of gastroesophageal reflux disease during which the normal esophageal lining changes to tissue that resembles intestinal lining. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.